Enhancement of the surface expression of tumor necrosis factor α (TNFα) but not the p55 TNFα receptor in the THP-1 monocytic cell line by matrix metalloprotease inhibitors

被引:22
作者
Glaser, KB [1 ]
Pease, L [1 ]
Li, JL [1 ]
Morgan, DW [1 ]
机构
[1] Abbott Labs, Canc Res, Abbott Pk, IL 60064 USA
关键词
tumor necrosis factor alpha (TNF alpha); THP-1; cells; tumor necrosis factor alpha converting enzyme (TACE); matrix metalloprotease inhibitors; tumor necrosis factor alpha receptors I and II; fluorescence activated cell sorting (FACS);
D O I
10.1016/S0006-2952(98)00300-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The monocytic cell line THP-1 can be induced to express and release tumor necrosis factor alpha (TNF alpha) and both TNF alpha receptors (p55 and p75) upon exposure to bacterial lipopolysaccharide (LPS). The broad-spectrum matrix metalloprotease (MMP) inhibitors [4-(N-hydroxyamino)-2R-isobutyl-3S-(phenylthiomethyl)succinyl]-L-phenylalanine-N-methylamide (GI-129471) and marimastat [2S-[N4(R*,3S*)]]-N4-[2,2-dimethyl-1-[(methylamino)carbonyl]propyl]-N1,2-dihydroxy-3-(2-methylpropyl)butanediamide (BB-2516) were effective inhibitors of LPS-induced TNF alpha (soluble) release with IC50 values of 0.2 and 4.0 mu M, respectively. Upon LPS stimulation, the expression pro-TNF-alpha (membrane associated) on the cell surface (FACS analysis) could not be observed. However, in the presence of GI-129471, a concentration-dependent increase in TNF alpha surface expression was observed. Peak expression (percentage of cells expressing pro-TNF alpha and mean fluorescence units) in the presence of GI-129471 was at 2 hr, and steadily declined to return to near control levels by 8 hr. This time course was similar to TNF alpha release, which also peaked at 2-4 hr after LPS exposure and then declined. Stimulation of THP-1 cells with LPS + phorbol myristate acetate increased the percentage of cells expressing pro-TNF alpha by 10-fold. In the presence of GI-129471, these increases were augmented further and peaked between 2 and 4 hr, but also returned to near control levels of expression by 24 hr. This was in contrast to te release of soluble TNF alpha, which continued to accumulate over a 24-hr time course. TNF alpha receptor I (p55, TNFRI) and 11 (p75, TNFR11) shedding was also inhibited by GI-129471 (IC50 = 1.5 and 3.1 mu M, respectively) and BB-2516 (IC50 = 14 and 15 mu M, respectively). Unlike pro-TNF alpha surface expression, TNFRI surface expression was not augmented by these MMP inhibitors. These results suggest that even in the continued presence of LPS stimulation and an inhibitor of TNF alpha processing, the augmented surface expression of TNF alpha is transient. The potential "deleterious" implications of high levels of surface pro-TNF alpha expression in the presence of these inhibitors may be lessened by its transient nature. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:291 / 302
页数:12
相关论文
共 38 条
[1]   A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling [J].
Alexopoulou, L ;
Pasparakis, M ;
Kollias, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (10) :2588-2592
[2]   Recent advances in matrix metalloproteinase inhibitor research [J].
Beckett, RP ;
Davidson, AH ;
Drummond, AH ;
Huxley, P ;
Whittaker, M .
DRUG DISCOVERY TODAY, 1996, 1 (01) :16-26
[3]   METALLOPROTEASES AND SERINE PROTEASES ARE INVOLVED IN THE CLEAVAGE OF THE 2 TUMOR-NECROSIS-FACTOR (TNF) RECEPTORS TO SOLUBLE FORMS IN THE MYELOID CELL-LINES U-937 AND THP-1 [J].
BJORNBERG, F ;
LANTZ, M ;
GULLBERG, U .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1995, 42 (04) :418-424
[4]   A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells [J].
Black, RA ;
Rauch, CT ;
Kozlosky, CJ ;
Peschon, JJ ;
Slack, JL ;
Wolfson, MF ;
Castner, BJ ;
Stocking, KL ;
Reddy, P ;
Srinivasan, S ;
Nelson, N ;
Boiani, N ;
Schooley, KA ;
Gerhart, M ;
Davis, R ;
Fitzner, JN ;
Johnson, RS ;
Paxton, RJ ;
March, CJ ;
Cerretti, DP .
NATURE, 1997, 385 (6618) :729-733
[5]   Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-alpha (TNF-alpha) production suggest the major TNF-alpha converting enzyme is not an MMP [J].
Black, RA ;
Durie, FH ;
OttenEvans, C ;
Miller, R ;
Slack, JL ;
Lynch, DH ;
Castner, B ;
Mohler, KM ;
Gerhart, M ;
Johnson, RS ;
Itoh, Y ;
Okada, Y ;
Nagase, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 225 (02) :400-405
[6]   Differential regulation of biosynthesis of cell surface and secreted TNF-alpha in LPS-stimulated murine macrophages [J].
Chaudhri, G .
JOURNAL OF LEUKOCYTE BIOLOGY, 1997, 62 (02) :249-257
[7]   A METALLOPROTEASE INHIBITOR BLOCKS SHEDDING OF THE 80-KD TNF RECEPTOR AND TNF PROCESSING IN T-LYMPHOCYTES [J].
CROWE, PD ;
WALTER, BN ;
MOHLER, KM ;
OTTENEVANS, C ;
BLACK, RA ;
WARE, CF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03) :1205-1210
[8]   GENERATION AND BIOLOGICAL CHARACTERIZATION OF MEMBRANE-BOUND, UNCLEAVABLE MURINE TUMOR-NECROSIS-FACTOR [J].
DECOSTER, E ;
VANHAESEBROECK, B ;
VANDENABEELE, P ;
GROOTEN, J ;
FIERS, W .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (31) :18473-18478
[9]   RANDOMIZED DOUBLE-BLIND COMPARISON OF CHIMERIC MONOCLONAL-ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA (CA2) VERSUS PLACEBO IN RHEUMATOID-ARTHRITIS [J].
ELLIOTT, MJ ;
MAINI, RN ;
FELDMANN, M ;
KALDEN, JR ;
ANTONI, C ;
SMOLEN, JS ;
LEEB, B ;
BREEDVELD, FC ;
MACFARLANE, JD ;
BIJL, H ;
WOODY, JN .
LANCET, 1994, 344 (8930) :1105-1110
[10]   ANTI-CYTOKINE THERAPY IN RHEUMATOID-ARTHRITIS [J].
ELLIOTT, MJ ;
MAINI, RN .
BAILLIERES CLINICAL RHEUMATOLOGY, 1995, 9 (04) :633-652